Gap of Undiagnosed TB Cases Narrows as Global Response Rebounds from COVID 24/03/2023 Elaine Ruth Fletcher After major setbacks during the pandemic, TB diagnosis and treatment appears to have rebounded with the number of undiagnosed TB-infections estimated at less than three million people in 2022- the lowest ever. That’s according to preliminary data released by the Stop TB Partnership, on Friday, World TB Day. “In 2022 the gap between the estimated […] Continue reading -> U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Pathogen Sharing: Pandemic Accord Could Offer Solutions or Further Tangle the Web of Confusion 17/02/2023 Elaine Ruth Fletcher Just 66 days after the SARS-CoV2 genetic sequence was shared by a Chinese scientist online, the first COVID-19 vaccines went into production – in record time for R&D that yielded the first approved vaccines less than a year later. But there are looming concerns that the relatively open models of data and pathogen sharing that […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> UK Scientists Launch Genomic Surveillance System for Respiratory Viruses 12/01/2023 Stefan Anderson British scientists have launched a new initiative to expand the sequencing of common seasonal respiratory viruses with the aim of developing an early warning system for new viral threats and help prevent future pandemics. At the height of the COVID-19 pandemic, labs around the world were sequencing tens of thousands of Sars-CoV-2 genomes a day. […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
U.S. Government Invested $31.9 Billion in mRNA Vaccine Research and Procurement 02/03/2023 Stefan Anderson A new study published in the BMJ has found that the United States invested at least $31.9 billion in public funds directly into the development, production and purchasing of mRNA COVID-19 vaccines through channels ranging from the National Institutes of Health to the Department of Defense. That vast pool of U.S. public funding was indispensable […] Continue reading -> Pathogen Sharing: Pandemic Accord Could Offer Solutions or Further Tangle the Web of Confusion 17/02/2023 Elaine Ruth Fletcher Just 66 days after the SARS-CoV2 genetic sequence was shared by a Chinese scientist online, the first COVID-19 vaccines went into production – in record time for R&D that yielded the first approved vaccines less than a year later. But there are looming concerns that the relatively open models of data and pathogen sharing that […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> UK Scientists Launch Genomic Surveillance System for Respiratory Viruses 12/01/2023 Stefan Anderson British scientists have launched a new initiative to expand the sequencing of common seasonal respiratory viruses with the aim of developing an early warning system for new viral threats and help prevent future pandemics. At the height of the COVID-19 pandemic, labs around the world were sequencing tens of thousands of Sars-CoV-2 genomes a day. […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pathogen Sharing: Pandemic Accord Could Offer Solutions or Further Tangle the Web of Confusion 17/02/2023 Elaine Ruth Fletcher Just 66 days after the SARS-CoV2 genetic sequence was shared by a Chinese scientist online, the first COVID-19 vaccines went into production – in record time for R&D that yielded the first approved vaccines less than a year later. But there are looming concerns that the relatively open models of data and pathogen sharing that […] Continue reading -> Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> UK Scientists Launch Genomic Surveillance System for Respiratory Viruses 12/01/2023 Stefan Anderson British scientists have launched a new initiative to expand the sequencing of common seasonal respiratory viruses with the aim of developing an early warning system for new viral threats and help prevent future pandemics. At the height of the COVID-19 pandemic, labs around the world were sequencing tens of thousands of Sars-CoV-2 genomes a day. […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Amid Scarcity and Soaring Prices, China Could Issues Compulsory License for Paxlovid 09/02/2023 Zhenyan Zhu, Yuanqiong Hu & Guangjian Xue After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of […] Continue reading -> Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> UK Scientists Launch Genomic Surveillance System for Respiratory Viruses 12/01/2023 Stefan Anderson British scientists have launched a new initiative to expand the sequencing of common seasonal respiratory viruses with the aim of developing an early warning system for new viral threats and help prevent future pandemics. At the height of the COVID-19 pandemic, labs around the world were sequencing tens of thousands of Sars-CoV-2 genomes a day. […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> UK Scientists Launch Genomic Surveillance System for Respiratory Viruses 12/01/2023 Stefan Anderson British scientists have launched a new initiative to expand the sequencing of common seasonal respiratory viruses with the aim of developing an early warning system for new viral threats and help prevent future pandemics. At the height of the COVID-19 pandemic, labs around the world were sequencing tens of thousands of Sars-CoV-2 genomes a day. […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UK Scientists Launch Genomic Surveillance System for Respiratory Viruses 12/01/2023 Stefan Anderson British scientists have launched a new initiative to expand the sequencing of common seasonal respiratory viruses with the aim of developing an early warning system for new viral threats and help prevent future pandemics. At the height of the COVID-19 pandemic, labs around the world were sequencing tens of thousands of Sars-CoV-2 genomes a day. […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Posts navigation Older posts